Alkyl Amines Chemicals has reported its Q3 standalone financial results, showing a challenging performance with revenue, net profit, and EBITDA all declining year-on-year. The specialty chemicals manufacturer recorded revenue of ₹3.5B rupees compared to ₹3.7B rupees in the corresponding quarter of the previous year, alongside a net profit decline to ₹423 million.

Q3 Financial Performance Overview

The company's financial metrics across key parameters showed a declining trend during the quarter. Revenue dropped to ₹3.5B rupees from ₹3.7B rupees in the year-ago quarter, while standalone net profit decreased to ₹423 million from ₹438 million recorded in the same quarter of the previous fiscal year.

Revenue and Profitability Analysis

The revenue decline from ₹3.7B rupees to ₹3.5B rupees indicates challenging market conditions for the company during the quarter. This revenue pressure contributed to the overall financial performance decline, with net profit falling by approximately 3.40% year-on-year. The company's EBITDA also witnessed a decline, reaching ₹672 million compared to ₹709 million in the year-ago quarter, representing a year-on-year decline of approximately 5.22%.

Operational Efficiency Metrics

The EBITDA margin compressed to 18.97% from 19.11% in the corresponding quarter of the previous year, indicating pressure on operational efficiency. This margin compression of 14 basis points reflects the challenging operating environment faced by the company, with both top-line and bottom-line metrics showing year-on-year declines during the quarter.

Company Overview

Alkyl Amines Chemicals operates in the specialty chemicals sector, focusing on the manufacturing and distribution of various chemical products. The Q3 results highlight the company's recent financial challenges, with revenue, profitability, and operational metrics all showing year-on-year declines, reflecting broader market pressures in the specialty chemicals industry.

Alkyl amines chemicals Limited has announced that its Board of Directors will meet on February 3, 2026, to review and approve the company's unaudited financial results for the third quarter of fiscal year 2026.

Board Meeting Details

The meeting has been scheduled in accordance with regulatory requirements and will focus on the financial performance for specific reporting periods.

Regulatory Compliance

The announcement was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally notified both major stock exchanges about the upcoming board meeting.

Stock Exchange Communication

Alkyl Amines Chemicals Limited communicated the board meeting schedule to both BSE Limited and The National Stock Exchange of India Limited on January 16, 2026. The notification was signed by Chintamani D. Thatte, General Manager (Legal) & Company Secretary & Compliance Officer.

The company referenced a previous communication dated December 29, 2025, indicating this announcement serves as a follow-up to earlier correspondence regarding the financial results review process.

Meeting Agenda

The primary agenda item for the February 3, 2026 board meeting will be the consideration and approval of unaudited financial results. The results will cover both the quarterly performance for the period ended December 31, 2025, and the cumulative nine-month performance for the same fiscal year period.